Mitochondrial VDAC1: A key gatekeeper as potential therapeutic target

Amadou K.S. Camara, Yi Fan Zhou, Po Chao Wen, Emad Tajkhorshid, Wai Meng Kwok

Research output: Contribution to journalReview article

Abstract

Mitochondria are the key source of ATP that fuels cellular functions, and they are also central in cellular signaling, cell division and apoptosis. Dysfunction of mitochondria has been implicated in a wide range of diseases, including neurodegenerative and cardiac diseases, and various types of cancer. One of the key proteins that regulate mitochondrial function is the voltage-dependent anion channel 1 (VDAC1), the most abundant protein on the outer membrane of mitochondria. VDAC1 is the gatekeeper for the passages of metabolites, nucleotides, and ions; it plays a crucial role in regulating apoptosis due to its interaction with apoptotic and anti-apoptotic proteins, namely members of the Bcl-2 family of proteins and hexokinase. Therefore, regulation of VDAC1 is crucial not only for metabolic functions of mitochondria, but also for cell survival. In fact, multiple lines of evidence have confirmed the involvement of VDAC1 in several diseases. Consequently, modulation or dysregulation of VDAC1 function can potentially attenuate or exacerbate pathophysiological conditions. Understanding the role of VDAC1 in health and disease could lead to selective protection of cells in different tissues and diverse diseases. The purpose of this review is to discuss the role of VDAC1 in the pathogenesis of diseases and as a potentially effective target for therapeutic management of various pathologies.

Original languageEnglish (US)
Article number460
JournalFrontiers in Physiology
Volume8
Issue numberJUN
DOIs
StatePublished - Jun 30 2017

Fingerprint

Voltage-Dependent Anion Channel 1
Mitochondria
Therapeutics
Apoptosis
Apoptosis Regulatory Proteins
Hexokinase
Cytoprotection
Mitochondrial Proteins
Neurodegenerative Diseases
Cell Division
Heart Diseases
Cell Survival
Proteins
Nucleotides
Adenosine Triphosphate
Ions
Pathology

Keywords

  • Alzheimer's disease
  • Cardiac ischemia/reperfusion
  • Hexokinase
  • Mitochondria
  • Molecular dynamics
  • Neoplastic diseases
  • Post-translational modification
  • Voltage dependent anion channel

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)

Cite this

Mitochondrial VDAC1 : A key gatekeeper as potential therapeutic target. / Camara, Amadou K.S.; Zhou, Yi Fan; Wen, Po Chao; Tajkhorshid, Emad; Kwok, Wai Meng.

In: Frontiers in Physiology, Vol. 8, No. JUN, 460, 30.06.2017.

Research output: Contribution to journalReview article

Camara, Amadou K.S. ; Zhou, Yi Fan ; Wen, Po Chao ; Tajkhorshid, Emad ; Kwok, Wai Meng. / Mitochondrial VDAC1 : A key gatekeeper as potential therapeutic target. In: Frontiers in Physiology. 2017 ; Vol. 8, No. JUN.
@article{cea3e408a25249ed89825a135b69f7e0,
title = "Mitochondrial VDAC1: A key gatekeeper as potential therapeutic target",
abstract = "Mitochondria are the key source of ATP that fuels cellular functions, and they are also central in cellular signaling, cell division and apoptosis. Dysfunction of mitochondria has been implicated in a wide range of diseases, including neurodegenerative and cardiac diseases, and various types of cancer. One of the key proteins that regulate mitochondrial function is the voltage-dependent anion channel 1 (VDAC1), the most abundant protein on the outer membrane of mitochondria. VDAC1 is the gatekeeper for the passages of metabolites, nucleotides, and ions; it plays a crucial role in regulating apoptosis due to its interaction with apoptotic and anti-apoptotic proteins, namely members of the Bcl-2 family of proteins and hexokinase. Therefore, regulation of VDAC1 is crucial not only for metabolic functions of mitochondria, but also for cell survival. In fact, multiple lines of evidence have confirmed the involvement of VDAC1 in several diseases. Consequently, modulation or dysregulation of VDAC1 function can potentially attenuate or exacerbate pathophysiological conditions. Understanding the role of VDAC1 in health and disease could lead to selective protection of cells in different tissues and diverse diseases. The purpose of this review is to discuss the role of VDAC1 in the pathogenesis of diseases and as a potentially effective target for therapeutic management of various pathologies.",
keywords = "Alzheimer's disease, Cardiac ischemia/reperfusion, Hexokinase, Mitochondria, Molecular dynamics, Neoplastic diseases, Post-translational modification, Voltage dependent anion channel",
author = "Camara, {Amadou K.S.} and Zhou, {Yi Fan} and Wen, {Po Chao} and Emad Tajkhorshid and Kwok, {Wai Meng}",
year = "2017",
month = "6",
day = "30",
doi = "10.3389/fphys.2017.00460",
language = "English (US)",
volume = "8",
journal = "Frontiers in Physiology",
issn = "1664-042X",
publisher = "Frontiers Research Foundation",
number = "JUN",

}

TY - JOUR

T1 - Mitochondrial VDAC1

T2 - A key gatekeeper as potential therapeutic target

AU - Camara, Amadou K.S.

AU - Zhou, Yi Fan

AU - Wen, Po Chao

AU - Tajkhorshid, Emad

AU - Kwok, Wai Meng

PY - 2017/6/30

Y1 - 2017/6/30

N2 - Mitochondria are the key source of ATP that fuels cellular functions, and they are also central in cellular signaling, cell division and apoptosis. Dysfunction of mitochondria has been implicated in a wide range of diseases, including neurodegenerative and cardiac diseases, and various types of cancer. One of the key proteins that regulate mitochondrial function is the voltage-dependent anion channel 1 (VDAC1), the most abundant protein on the outer membrane of mitochondria. VDAC1 is the gatekeeper for the passages of metabolites, nucleotides, and ions; it plays a crucial role in regulating apoptosis due to its interaction with apoptotic and anti-apoptotic proteins, namely members of the Bcl-2 family of proteins and hexokinase. Therefore, regulation of VDAC1 is crucial not only for metabolic functions of mitochondria, but also for cell survival. In fact, multiple lines of evidence have confirmed the involvement of VDAC1 in several diseases. Consequently, modulation or dysregulation of VDAC1 function can potentially attenuate or exacerbate pathophysiological conditions. Understanding the role of VDAC1 in health and disease could lead to selective protection of cells in different tissues and diverse diseases. The purpose of this review is to discuss the role of VDAC1 in the pathogenesis of diseases and as a potentially effective target for therapeutic management of various pathologies.

AB - Mitochondria are the key source of ATP that fuels cellular functions, and they are also central in cellular signaling, cell division and apoptosis. Dysfunction of mitochondria has been implicated in a wide range of diseases, including neurodegenerative and cardiac diseases, and various types of cancer. One of the key proteins that regulate mitochondrial function is the voltage-dependent anion channel 1 (VDAC1), the most abundant protein on the outer membrane of mitochondria. VDAC1 is the gatekeeper for the passages of metabolites, nucleotides, and ions; it plays a crucial role in regulating apoptosis due to its interaction with apoptotic and anti-apoptotic proteins, namely members of the Bcl-2 family of proteins and hexokinase. Therefore, regulation of VDAC1 is crucial not only for metabolic functions of mitochondria, but also for cell survival. In fact, multiple lines of evidence have confirmed the involvement of VDAC1 in several diseases. Consequently, modulation or dysregulation of VDAC1 function can potentially attenuate or exacerbate pathophysiological conditions. Understanding the role of VDAC1 in health and disease could lead to selective protection of cells in different tissues and diverse diseases. The purpose of this review is to discuss the role of VDAC1 in the pathogenesis of diseases and as a potentially effective target for therapeutic management of various pathologies.

KW - Alzheimer's disease

KW - Cardiac ischemia/reperfusion

KW - Hexokinase

KW - Mitochondria

KW - Molecular dynamics

KW - Neoplastic diseases

KW - Post-translational modification

KW - Voltage dependent anion channel

UR - http://www.scopus.com/inward/record.url?scp=85021639636&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021639636&partnerID=8YFLogxK

U2 - 10.3389/fphys.2017.00460

DO - 10.3389/fphys.2017.00460

M3 - Review article

AN - SCOPUS:85021639636

VL - 8

JO - Frontiers in Physiology

JF - Frontiers in Physiology

SN - 1664-042X

IS - JUN

M1 - 460

ER -